Search by Drug Name or NDC
NDC 00591-5513-01 Carisoprodol 350 mg/1 Details
Carisoprodol 350 mg/1
Carisoprodol is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is CARISOPRODOL.
MedlinePlus Drug Summary
Carisoprodol is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Carisoprodol is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous system to allow the muscles to relax.
Related Packages: 00591-5513-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Carisoprodol
Product Information
| NDC | 00591-5513 |
|---|---|
| Product ID | 0591-5513_93954d60-cc97-48ac-ad9d-2e9c32be6bc5 |
| Associated GPIs | 75100020000305 |
| GCN Sequence Number | 004663 |
| GCN Sequence Number Description | carisoprodol TABLET 350 MG ORAL |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 17912 |
| HICL Sequence Number | 001944 |
| HICL Sequence Number Description | CARISOPRODOL |
| Brand/Generic | Generic |
| Proprietary Name | Carisoprodol |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Carisoprodol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 350 |
| Active Ingredient Units | mg/1 |
| Substance Name | CARISOPRODOL |
| Labeler Name | Actavis Pharma, Inc. |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA087499 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00591-5513-01 (00591551301)
| NDC Package Code | 0591-5513-01 |
|---|---|
| Billing NDC | 00591551301 |
| Package | 100 TABLET in 1 BOTTLE (0591-5513-01) |
| Marketing Start Date | 1987-11-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.07121 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CARISOPRODOL 350 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis